Hikma Pharmaceuticals (HKMPY) Stock Price, News & Analysis

Company Overview

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Key Stats

• Today's Range: $46.40 to $46.40
• 50-Day Range: $46.22 to $53.00
• 52-Week Range: $42.51 to $55.56
• Volume: 248 shs
• Average Volume: 699 shs
• Market Capitalization: N/A
• P/E Ratio: 14.99
• Dividend Yield: 0.69%
• Price Target: N/A
• Consensus Rating: N/A

HKMPY Stock Analysis - Frequently Asked Questions

How have HKMPY shares performed this year?

Hikma Pharmaceuticals' stock was trading at $45.4110 at the beginning of the year. Since then, HKMPY shares have increased by 2.2% and is now trading at $46.3950.
View the best growth stocks for 2024 here.

How do I buy shares of Hikma Pharmaceuticals?

Shares of HKMPY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Ex-Dividend for 9/30 Dividend: 8/19/2024
• Dividend Payable: 9/30/2024
• Today: 11/21/2024

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:HKMPY
• CUSIP: N/A
• CIK: N/A
• Web: www.hikma.com
• Phone: 442073992760
• Fax: N/A
• Employees: 9,100
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 14.99
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A